BioPower Operations Corporation
BOPO
$0.00
$0.000.00%
OTC PK
| 05/31/2023 | 02/28/2023 | 11/30/2022 | 08/31/2022 | 05/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -79.89% | -0.88% | 226.69% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -79.89% | -0.88% | 226.69% | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -79.89% | -0.88% | 226.69% | -- | -- |
| SG&A Expenses | 548.35% | 73.49% | 152.22% | 386.44% | 9,986.42% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 631.71% | 144.05% | 152.22% | 386.44% | 9,986.42% |
| Operating Income | -2,896.98% | -372.70% | -106.71% | -30.02% | -2,311.11% |
| Income Before Tax | -1,521.75% | -249.10% | -79.58% | -8.67% | -176.18% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1,521.75% | -249.10% | -79.58% | -8.67% | -176.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,521.75% | -249.10% | -79.58% | -8.67% | -176.18% |
| EBIT | -2,896.98% | -372.70% | -106.71% | -30.02% | -2,311.11% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -1,466.28% | -240.22% | -76.77% | -3.75% | -177.42% |
| Normalized Basic EPS | -1,457.41% | -236.21% | -73.02% | -1.96% | -157.14% |
| EPS Diluted | -1,466.28% | -240.22% | -76.77% | -3.75% | -177.42% |
| Normalized Diluted EPS | -1,457.41% | -236.21% | -73.02% | -1.96% | -157.14% |
| Average Basic Shares Outstanding | 1.31% | 2.57% | 2.22% | 4.08% | 3.17% |
| Average Diluted Shares Outstanding | 1.31% | 2.57% | 2.22% | 4.08% | 3.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |